Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a Wound (PMCS EURO HEAL)

• Effectiveness [ Time Frame: Assessed at Months 1, 3, 6, 9 and 12 ] [ Designated as safety issue: No ]
  Patient and Observer Scar Assessment Scale (POSAS)
• Device Performance Evaluation [ Time Frame: Assessed at Day 1 ] [ Designated as safety issue: No ]
  Questions related to packaging integrity and successful administration of product as assessed by the Principal Investigator

The objective of the study is to actively gather additional information on safety, device performance and possible emergent risks following the use of Celotres in a post-market setting when used to improve wound healing and the resulting scar consequences following suturing of a wound.

• Other: Celotres
  Surgical procedure will be performed as per the standard of care. Scar halves randomized to treatment with device (Celotres), opposite side treated per standard of care.
• Other: Surgical Closure by Standard of Care
  Surgical procedure will be performed as per the standard of care. Scar halves randomized to treatment with device (Celotres), opposite side treated per standard of care.

• Active Comparator: Celotres
  Scar halves randomized to treatment with device, opposite side treated per standard of care.
  Intervention: Other: Celotres
• Active Comparator: Standard surgical wound closure
  Scar halves randomized to treatment with device, opposite side treated per standard of care.
  Intervention: Other: Surgical Closure by Standard of Care

Inclusion Criteria:

• Patients electing to undergo a surgical procedure;
• Patients able and willing to give written informed consent

Exclusion Criteria:

• Patients with a known or potential risk of allergy or sensitivity to products or substances containing porcine gelatin